COMPLEMENT-DERIVED CHEMOTACTIC ACTIVITY IS GENERATED IN HUMAN-SERUM CONTAINING UROPORPHYRIN AFTER IRRADIATION WITH 405 NM LIGHT

被引:24
作者
LIM, HW
PEREZ, HD
GOLDSTEIN, IM
GIGLI, I
机构
[1] NYU MED CTR, DEPT DERMATOL, NEW YORK, NY 10016 USA
[2] NYU MED CTR, DEPT MED, NEW YORK, NY 10016 USA
关键词
D O I
10.1172/JCI110119
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Patients with porphyrias have varying degrees of photosensitivity, associated with elevated levels of porphyrins in plasma, erythrocyte, urine and/or feces. To investigate the role of complement in the pathogenesis of cutaneous lesions, varying amounts of uroporphyrin were added to normal human serum (0.1-10 .mu.g/ml), and the mixtures were then exposed to 405 nm irradiation. Such treatments result in the diminution of total hemolytic complement activity and hemolytic titers of C1, C4, C2, C3 and C5; furthermore, cleavage products of C3 and C5 were detected. Chemotactic activity of human polymorphonuclear leukocytes was generated that was inhibitable by incubation with anti-C5, but not with anti-C3 antisera. No chemotactic activity was generated in Mg2+-EGTA [ethylene glycol bis(2-anion ethyl ether)-N,N''-tetraacetic acid] treated serum nor in C4-deficient guinea pig serum. Irradiation with 405 nm light of normal human serum containing uroporphyrin results in activation of the complement system via the classical pathway, and the generation of complement (C5)-derived chemotactic activity for human polymorphonuclear leukocytes.
引用
收藏
页码:1072 / 1077
页数:6
相关论文
共 17 条
[1]  
DELAFAILLE HB, 1975, THESIS UTRECHT U OOS
[2]   CUTANEOUS CHANGES IN PORPHYRIAS - MICROSCOPIC STUDY [J].
EPSTEIN, JH ;
TUFFANELLI, DL ;
EPSTEIN, WL .
ARCHIVES OF DERMATOLOGY, 1973, 107 (05) :689-698
[3]  
Everett M A, 1966, Photochem Photobiol, V5, P533
[4]   ERYTHROPOIETIC PROTOPORPHYRIA - PHOTOACTIVATION OF THE COMPLEMENT-SYSTEM [J].
GIGLI, I ;
SCHOTHORST, AA ;
SOTER, NA ;
PATHAK, MA .
JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (03) :517-522
[5]  
GIGLI I, 1979, CLIN EXP DERMATOL, V4, P271, DOI 10.1111/j.1365-2230.1979.tb02640.x
[7]   PORPHYRIA CUTANEA-TARDA - CLINICAL-FEATURES AND LABORATORY FINDINGS IN 40 PATIENTS [J].
GROSSMAN, ME ;
BICKERS, DR ;
POHFITZPATRICK, MB ;
DELEO, VA ;
HARBER, LC .
AMERICAN JOURNAL OF MEDICINE, 1979, 67 (02) :277-286
[8]  
HARBER LC, 1975, YB DERMATOLOGY, P9
[9]   MOUSE MODEL FOR PROTOPORPHYRIA .3. EXPERIMENTAL PRODUCTION OF CHRONIC ERYTHROPOIETIC PROTOPORPHYRIA-LIKE SKIN-LESIONS [J].
HONIGSMANN, H ;
GSCHNAIT, F ;
KONRAD, K ;
STINGL, G ;
WOLFF, K .
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1976, 66 (03) :188-195
[10]  
KANEKO I, 1980, J IMMUNOL, V124, P1194